Serum biomarker analysis to identify subtypes of atopic dermatitis in China and to help with predicting the effectiveness of treatment with dupilumab
- PMID: 37078765
- DOI: 10.1093/bjd/ljad091
Serum biomarker analysis to identify subtypes of atopic dermatitis in China and to help with predicting the effectiveness of treatment with dupilumab
Comment on
-
Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab.Br J Dermatol. 2023 Apr 20;188(5):649-660. doi: 10.1093/bjd/ljad032. Br J Dermatol. 2023. PMID: 36756674
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
